Basic information Safety Supplier Related

BUSULFAN-D8

Basic information Safety Supplier Related

BUSULFAN-D8 Basic information

Product Name:
BUSULFAN-D8
Synonyms:
  • Busulfan-D8(tetramethylene)
  • 1,4-Butanediol-d8-dimethanesulfonate Esters
  • Busulfan-d8
  • Busulfex-d8
  • Busulphan-d8
  • CB-2041-d8
  • GT-41-d8
  • Misulban-d8
CAS:
116653-28-2
MF:
C6H6D8O6S2
MW:
254.35
Product Categories:
  • Isotope Labelled Compounds
  • Intermediates & Fine Chemicals
  • Isotope Labeled Compounds
  • Pharmaceuticals
  • Sulfur & Selenium Compounds
Mol File:
116653-28-2.mol
More
Less

BUSULFAN-D8 Chemical Properties

Melting point:
112-1140C
storage temp. 
-20°C Freezer
solubility 
DMF: 16.7 mg/ml,DMSO: 16.7 mg/ml,DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml
form 
A crystalline solid
color 
White to off-white
CAS Number Unlabeled
55-98-1
More
Less

BUSULFAN-D8 Usage And Synthesis

Description

Busulfan-d8 is intended for use as an internal standard for the quantification of busulfan by GC- or LC-MS. Busulfan is an alkyl sulfonate that acts as an alkylating antineoplastic agent. It forms both intra- and interstrand crosslinks on DNA. In mammals, busulfan causes profound and prolonged reduction in the generation of hematopoietic progenitors without significantly affecting lymphocyte levels or humoral antibody responses.

Chemical Properties

White Solid

Uses

Alkylating agent with antileukemic activity. Antineoplastic

References

[1] APPELBAUM F. Is there a best transplant conditioning regimen for acute myeloid leukemia?[J]. Leukemia, 2000, 14 3: 497-501. DOI: 10.1038/sj.leu.2401601
[2] TAKUYA IWAMOTO. DNA intrastrand cross-link at the 5′-GA-3′ sequence formed by busulfan and its role in the cytotoxic effect[J]. Cancer Science, 2005, 95 5: 454-458. DOI: 10.1111/j.1349-7006.2004.tb03231.x
[3] M PONTI. DNA interstrand crosslinking and sequence selectivity of dimethanesulphonates[J]. British Journal of Cancer, 1991, 63 5: 743-747. DOI: 10.1038/bjc.1991.166
[4] E. COPELAN H D. Conditioning for allogeneic marrow transplantation in patients with lymphohematopoietic malignancies without the use of total body irradiation.[J]. Blood, 1992, 24 1: 1648-1658. DOI: 10.1182/blood.v80.7.1648.1648

BUSULFAN-D8Supplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366 13670046396
Email
sales@chem-strong.com
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com
Nanjing Haolv Biotechnology Co.,Ltd
Tel
025-84622273 17361806303
Email
kexin.zhou@haolvbiotech.com